Seguimiento de 12 meses de pacientes complejos tratados con stents farmacológicos liberadores de everolimus XIENCE V® en la práctica diaria – resultados del registro brasileño BRAVO
Fabio Conejo, Henrique Barbosa Ribeiro, André Gasparini Spadaro, Roger Renault Godinho, Sandro M. Faig, Camila Gabrilaitis, Mariana Y. Okada, Alexandre Spósito, Carlos Vinícius Espirito-Santo,...
Daniel Chamié, Breno O. Almeida, Fábio Grandic, Evandro M. Filho, J. Ribamar Costa Jr., Ricardo Costa, Rodolfo Staicoa, Dimytri Siqueira, Fausto Feres, Luiz Fernando...
While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...
Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...
Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....
